Eli Lilly Acquires AtaiBeckley, Boosting Psychedelic Drug Market

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley signals a significant 'buy signal' for the market of psychedelic drugs aimed at treating mental health conditions, marking Big Pharma's growing acceptance of these previously stigmatized medications.